AstraZeneca Group News

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! AstraZeneca is closing in on a site for its new $500 million home in Cambridge, with a biomedical park just south of the English city the most likely site, property industry sources said.

Insiders may sell shares for any number of reasons, but conventional wisdom is that insiders really only buy shares of a company for one reason -- they believe the stock price will move higher and they want to profit from it.

's stock had its "neutral" rating reaffirmed by JP Morgan Cazenove in a research note issued on Monday, ARN reports.

's stock had its "hold" rating reiterated by equities research analysts at Panmure Gordon in a research note issued to investors on Monday, AnalystRatingsNetwork.com reports.

AstraZeneca PLC , Cubist Pharmaceuticals, Inc. , Astellas Pharma Inc. Said to Make Bids for Optimer Pharmaceuticals, Inc.

Dividend income accounts for around two-thirds of total returns, the actual rate of return taking into account both capital and income appreciation.

Approximately 25 million Americans suffer from asthma, which accounts for more than 3300 deaths each year.

This article is the second in a three part series about Array BioPharma Inc. , a biopharmaceutical company that is developing small molecule drug candidates for the treatment of cancers and other diseases.

's stock had its "neutral" rating reiterated by equities research analysts at JP Morgan Cazenove in a research note issued to investors on Tuesday, AnalystRatingsNetwork.com reports.

Shares of AstraZeneca traded down 0.08% during mid-day trading on Wednesday, hitting $51.54. AstraZeneca has a 52 week low of $39.72 and a 52 week high of $52.27. The stock's 50-day moving average is currently $50.92. The company has a market cap of $64.425 billion and a P/E ratio of 11.41. Other equities research analysts have also recently issued ... (more)

On May 8, 2013, Pozen reported financial results for the first quarter 2013. Pozen reported revenues in the quarter of $1.415 million, driven entirely by royalties on $19.7 million in worldwide sales of Vimovo at AstraZeneca .

Pozen's "nightmare" partnership is changing its terms, but what that might mean for the Chapel Hill company remains unclear.

's stock had its "equal weight" rating restated by equities researchers at Morgan Stanley in a report issued on Wednesday, Analyst Ratings Network reports.

VIVUS, Inc. Announces Richard Fante , Former President U.S. and CEO North America, AstraZeneca PLC , to Serve as Senior Advisor Staying up-to-date has never been simpler.

Cancer drug research company Array BioPharma Inc. reported lower revenue and higher losses for the most recent quarter compared with the same period a year ago.

The Supreme Court on April 12 upheld two high court rulings that said the state and the Japanese unit of British drug maker AstraZeneca PLC bore no liability for fatal side effects caused by the lung cancer drug Iressa.

Bristol-Myers Squibb Company , AstraZeneca PLC Release: Sub-Group Analysis Shows Investigational Metreleptin Treatment Demonstrated Reductions in HbA1c, Triglycerides and Liver Function Tests in Pediatric Patients With Lipodystrophy During a 12-Month Period Staying up-to-date has never been simpler.

's stock had its "hold" rating reaffirmed by research analysts at Jefferies Group in a report released on Thursday, StockRatingsNetwork reports.

's stock had its "neutral" rating reiterated by equities research analysts at JP Morgan Cazenove in a research note issued to investors on Thursday, ARN reports.

A.P. Pharma, Inc. , a specialty pharmaceutical company, today announced that its Board of Directors has appointed a new management team to lead the Company.